TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROCE(%) | 19.27 | 27.32 | 24.28 | 20.32 | 14.35 |
What is the latest Return on Capital Employed (ROCE) ratio of TORRENT PHARMACEUTICALS ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2026 | 19.27 |
| Mar2025 | 27.32 |
| Mar2024 | 24.28 |
| Mar2023 | 20.32 |
| Mar2022 | 14.35 |
How is Return on Capital Employed (ROCE) of TORRENT PHARMACEUTICALS Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2026 | 19.27 | -29.47 | |
| Mar2025 | 27.32 | 12.52 | |
| Mar2024 | 24.28 | 19.49 | |
| Mar2023 | 20.32 | 41.60 | |
| Mar2022 | 14.35 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹176,315.4 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
| MANKIND PHARMA | ₹102,315.0 Cr | -0.3% | -2% | 2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.6% |
-2.7% |
28.1% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses